In reply to @polybiorf

PolyBio

@polybiorf · Twitter · 2026-09-10 00:31 UTC

Further, awaiting unblinded data, MENSA results will be compared to other biological assays for Long COVID used in this trial that are simultaneously under development within PolyBio’s VIPER Biomarkers program. 8/end Background on VIPER: https://polybio.org/viper/